• Office: 2875 PST
  • Phone: 412-647-9121
  • Fax: 412-647-5847
  • Pager: 412-958-7848
  • Email: coonsjc@upmc.edu
orcidpubmed

James C. Coons, PharmD, BCPS (AQ-CV) is an associate professor in the Department of Pharmacy and Therapeutics at the School of Pharmacy and a clinical pharmacist specializing in cardiology at UPMC Presbyterian Shadyside. He is also the PGY-2 cardiology pharmacy residency program director at UPMC Presbyterian Shadyside.

After receiving his PharmD from the University of Pittsburgh in 2000, he completed a PGY-1 residency in pharmacy practice at the University of Virginia Health System in Charlottesville in 2002. From there, he returned to Pittsburgh to complete a PGY-2 specialty residency in cardiology pharmacy practice at the University of Pittsburgh in 2003.
From 2003 to 2012, Coons was a clinical pharmacy specialist in cardiology at Allegheny General Hospital (AGH) in Pittsburgh. During that time, he managed patients in the cardiac intensive care unit and those under the care of the advanced heart failure service. He also served as the PGY-1 residency program director at AGH from 2005 to 2012.

Coons' clinical practice sites at UPMC include the cardiac intensive care unit and the pulmonary hypertension clinic. His clinical interests are in the management of patients with acute coronary syndromes that undergo percutaneous coronary intervention as well as those with advanced heart failure and pulmonary vascular diseases.

Selected peer-reviewed publications:
Raina A, Coons JC, Kanwar M, et al. Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension. Pulm Circ 2013;3(1):116-120.

Kanwar M, Agarwal R, Barnes M, Coons J, et al. Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts. Curr Heart Fail Rep 2013;10:26-35.

Coons JC, Devabhakthuni S. Thrombolytics/Anticoagulants. In: Kane-Gill S, Dasta J, editors. High-risk IV medications in special patient populations. Amhert (MA): Springer-Verlag London Limited; 2011. p. 1-68.

Coons JC, McGraw M, Murali S. Pharmacotherapy for acute heart failure syndromes. Am J Health-Syst Pharm 2011;68:21-35.

Seybert AL, Coons JC. Atrial arrhythmias. In: Crouch MA, editor. Cardiovascular pharmacotherapy: a point-of-care guide. Bethesda (MD): American Society of Health-System Pharmacists Inc.; 2010. p. 235-57.

Coons JC, Plauger KM, Seybert AL, Sokos GG. Worsening heart failure in the setting of dronedarone initiation. Ann Pharmacother 2010;44:1496-1500.

Coons JC, Barnes M, Kusick K. Takotsubo cardiomyopathy. Am J Health-Syst Pharm 2009;66:562-6.

Coons JC, Battistone S. 2007 guideline update for unstable angina/ non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. Ann Pharmacother 2008;42:989-1001.

Coons JC, Fera T. Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure. Am J Health-Syst Pharm 2007;64:1274-8.

Coons JC, Seidl E. Cardiovascular pharmacotherapy update for the intensive care unit. Crit Care Nurs Q 2007;30(1):44-57.

Seybert AL, Coons JC, Zerumsky K. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? Pharmacotherapy 2006;26(2):229-41.

Coons JC, Seybert AL, Saul MI, Kirisci L, Kane-Gill SL. Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary intervention. Ann Pharmacother 2005;39:1621-26.

Grant total: $25,000. Coons JC, Empey PE, Smith AJ, Saul MI, Kirisci L, Skledar SJ, Sapienza SP. Pharmacist-Delivered Pharmacogenomic Care. American Society of Health-System Pharmacists (ASHP) Research and Education Foundation Pharmacy Practice Model Initiative (PPMI) Demonstration Grant. April 2013.